Equibles does not estimate personal net worth.
Get an email with a short summary when Simulations Plus, Inc. publishes a filing, an earnings call transcript or a press release.
Get SLP alertsJonathan Chauvin is recorded as CTO at Simulations Plus, Inc. (SLP) since May 30, 2025. Simulations Plus, Inc. reported in an 8-K filed June 2, 2025 that Jonathan Chauvin was appointed Co-Chief Product and Technology Officer, effective May 30, 2025. Jonathan Chauvin has spoken on 1 investor event across 1 company, most recently for Simulations Plus, Inc. on January 21, 2026. Simulations Plus, Inc. is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at Simulations Plus, Inc. includes Shawn O'Connor (CEO and Board Member), Will Frederick (CFO and COO), Josh Fohey (COO) and 7 others.
“Dr. Jonathan Chauvin, currently Business Unit Co-President, Clinical Pharmacology & Pharmacometric Solutions, assumes the new role of Co-Chief Product and Technology Officer.”
“For nearly 30 years, Simulations Plus has shaped the scientific backbone of model-informed drug development. Our modeling and simulations products, GastroPlus, Monolix Suite, Admet Predictor, DDCM, and our QSP platforms are used across the industry and inside regulatory agencies around the world.”
2025-05-30–present
Proxy statement
Start not stated–present
Last confirmed December 29, 2025
Health Information Services · Healthcare
CTO
2025-05-30–present
